Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
49.54
-0.11 (-0.22%)
At close: Apr 28, 2026, 4:00 PM EDT
49.39
-0.16 (-0.31%)
After-hours: Apr 28, 2026, 7:42 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $29.37 billion as of April 28, 2026. Its market cap has increased by 112.13% in one year.
Market Cap
29.37B
Enterprise Value
37.70B
1-Year Change
112.13%
Ranking
Category
Stock Price
$49.54
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $29.37B, an increase of 86.34%. That is a compound annual growth rate of 11.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 49.41B |
| Alnylam Pharmaceuticals | 40.92B |
| BeOne Medicines AG | 33.15B |
| Insmed | 29.35B |
| Revolution Medicines | 27.69B |
| BioNTech SE | 25.81B |
| Roivant Sciences | 19.93B |
| Moderna | 19.31B |